BioGaia reports Q2 2026 net sales of SEK 440.9 million
Operating profit increased 22% to SEK 132.1 million and adjusted operating margin reached 33%.
See the latest news and media coverage for BioGaia. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish probiotics company
biogaiagroup.comLast updated
In short: BioGaia reported strong financial growth throughout 2026, driven by a 12% increase in net sales and the expansion of its product portfolio.
Operating profit increased 22% to SEK 132.1 million and adjusted operating margin reached 33%.
She was elected at the Annual General Meeting in May and brings experience from Novonesis and DuPont Nutrition & Biosciences.
Shareholders approve financial statements, SEK 4.00 per share dividend, board elections, and Performance Share Program 2026/2029.
The next-generation dual-strain product combines L. reuteri Protectis and patented BG-R46 for enhanced digestive relief in colicky babies. It launches first in the UK.
Earnings call BioGaia delivered 7% reported sales growth (14% organic, excluding currency) in Q3, with EBIT margin expanding to 26% from 14% YoY due to...
Biogaia had net sales of 441 million kronor (405) in the second quarter of 2026, an increase excluding currency effects of 12 percent.
The latest announcement is out from BioGaia AB ( ($SE:BIOG.B) ). BioGaia AB's annual general meeting approved the 2025 financial statements, discharged the board ...
The probiotic company Biogaia increases the result and turnover slightly during the first quarter.
Track BioGaia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.